Prime Medicine Inc (PRME)

Dec 19, 2024

Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans? - Simply Wall St

Dec 19, 2024

Dec 17, 2024

Prime Medicine's SWOT analysis: gene editing firm's stock faces pivotal 2025 - Investing.com

Dec 17, 2024

Dec 17, 2024

When Would Be The Best Time To Buy Prime Medicine Inc (NASDAQ: PRME) Stock? - Stocks Register

Dec 17, 2024

Dec 14, 2024

Prime Medicine, Inc. (NYSE:PRME) Receives $12.67 Consensus Price Target from Analysts - Defense World

Dec 14, 2024

Dec 13, 2024

Prime Medicine Files for Resale of 11 Million Shares - Marketscreener.com

Dec 13, 2024

Dec 12, 2024

Layoff Tracker: Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff - BioSpace

Dec 12, 2024

Dec 11, 2024

Prime Medicine initiated with an Outperform at JMP Securities - MSN

Dec 11, 2024

Dec 11, 2024

Prime Medicine (NYSE:PRME) Stock Rating Upgraded by Citizens Jmp - MarketBeat

Dec 11, 2024

Dec 11, 2024

Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Dec 11, 2024

Dec 11, 2024

Fmr LLC Sells 184,541 Shares of Prime Medicine, Inc. (NYSE:PRME) - MarketBeat

Dec 11, 2024

Dec 10, 2024

Prime Medicine's SWOT analysis: gene editing firm's stock faces pivotal year - Investing.com Canada

Dec 10, 2024

Dec 10, 2024

Prime Medicine stock a top pick for gene editing, says JMP Securities - Investing.com Canada

Dec 10, 2024

Dec 10, 2024

Prime Medicine (NYSE:PRME) Now Covered by Analysts at JMP Securities - MarketBeat

Dec 10, 2024

Dec 09, 2024

Intech Investment Management LLC Acquires Shares of 14,102 Prime Medicine, Inc. (NYSE:PRME) - Defense World

Dec 09, 2024

Dec 05, 2024

Prime Medicine (NYSE:PRME) Earns Buy Rating from Guggenheim - Defense World

Dec 05, 2024

Nov 29, 2024

Vestal Point Capital LP Purchases 620,000 Shares of Prime Medicine, Inc. (NYSE:PRME) - MarketBeat

Nov 29, 2024

Nov 27, 2024

Comparing Century Therapeutics (NASDAQ:IPSC) & Prime Medicine (NYSE:PRME) - Defense World

Nov 27, 2024

Nov 26, 2024

Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies - Seeking Alpha

Nov 26, 2024

Nov 24, 2024

Oppenheimer & Co. Inc. Has $69,000 Stock Holdings in Prime Medicine, Inc. (NYSE:PRME) - Defense World

Nov 24, 2024

Nov 22, 2024

GSA Capital Partners LLP Invests $383,000 in Prime Medicine, Inc. (NYSE:PRME) - Defense World

Nov 22, 2024

Nov 19, 2024

Brokerages Set Prime Medicine, Inc. (NYSE:PRME) Target Price at $13.25 - Defense World

Nov 19, 2024

Nov 18, 2024

Chardan Capital Raises Earnings Estimates for Prime Medicine - MarketBeat

Nov 18, 2024

Nov 18, 2024

FY2024 EPS Forecast for Prime Medicine Increased by Analyst - Defense World

Nov 18, 2024

Nov 16, 2024

FY2024 EPS Estimates for Prime Medicine Reduced by Analyst - Defense World

Nov 16, 2024

Nov 16, 2024

Wedbush Forecasts Prime Medicine FY2024 Earnings - Defense World

Nov 16, 2024

Nov 16, 2024

Prime Medicine, Inc. (NYSE:PRME) Receives $13.25 Consensus Target Price from Analysts - MarketBeat

Nov 16, 2024

Nov 16, 2024

Prime Medicine (NYSE:PRME) Raised to Sell at StockNews.com - Defense World

Nov 16, 2024

Nov 15, 2024

FY2024 EPS Estimate for Prime Medicine Decreased by Analyst - MarketBeat

Nov 15, 2024

Nov 15, 2024

Brokers Issue Forecasts for Prime Medicine FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

Chardan Capital Issues Pessimistic Forecast for Prime Medicine (NYSE:PRME) Stock Price - Defense World

Nov 15, 2024

Nov 15, 2024

Prime Medicine (NYSE:PRME) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 15, 2024

Nov 13, 2024

Prime Medicine Reports Q3 2024 Financial Progress - TipRanks

Nov 13, 2024

Nov 13, 2024

Prime Medicine (NYSE:PRME) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 13, 2024

Nov 12, 2024

FMR LLC Bolsters Stake in Prime Medicine Inc - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Prime Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 12, 2024

Nov 08, 2024

ARK Investment Management LLC Lowers Stock Position in Prime Medicine, Inc. (NYSE:PRME) - MarketBeat

Nov 08, 2024

Nov 06, 2024

Prime Medicine to Participate in Upcoming Investor Conferences - The Manila Times

Nov 06, 2024

Oct 27, 2024

Head to Head Review: Prime Medicine (NYSE:PRME) and Invivyd (NASDAQ:IVVD) - Defense World

Oct 27, 2024

Oct 25, 2024

Prime Medicine (NYSE:PRME) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 25, 2024

Oct 25, 2024

Prime Medicine Spat with Tessera Rumbles on at ESGCT - Genetic Engineering & Biotechnology News

Oct 25, 2024

Oct 25, 2024

Prime Medicine receives Investment Bank Analyst Rating Update By Investing.com - Investing.com

Oct 25, 2024

Oct 25, 2024

Brokerages Set Prime Medicine, Inc. (NYSE:PRME) Price Target at $13.50 - Defense World

Oct 25, 2024

Oct 24, 2024

Prime Medicine Presents In Vivo Proof-of-Concept Data - GlobeNewswire

Oct 24, 2024

Oct 24, 2024

Prime Medicine Advances Gene Editing for Liver Diseases - TipRanks

Oct 24, 2024